About Spherotec
Spherotec is a company based in Planegg (Germany) founded in 2006 by Barbara Mayer and Ilona Funke. The company has 3 employees as of December 31, 2017. Spherotec offers products and services including Magnetic Beads, Rainbow Calibration, Sphero Beads, and Glutamine Assay Kit. Spherotec operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Planegg, Germany
- Employees 3 as on 31 Dec, 2017
- Founders Barbara Mayer, Ilona Funke
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Spherotec Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$54.46 K (USD), Grant
Apr 30, 2017
-
Investors
European Union
& 1 more
-
Employee Count
3
as on Dec 31, 2017
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spherotec
Spherotec offers a comprehensive portfolio of products and services, including Magnetic Beads, Rainbow Calibration, Sphero Beads, and Glutamine Assay Kit.
Products for early identification of active ingredients in therapies
Tools for optimizing drug development processes
Beads used in glycan-protein associations for vaccine research
Colorimetric kit for drug profiling and methodologies
Funding Insights of Spherotec
Investors in Spherotec
Spherotec has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Spherotec
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spherotec
Investment portfolio details for Spherotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spherotec
Detailed financials for Spherotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spherotec Comparisons
Peer comparison for Spherotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spherotec
Spherotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Spherotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spherotec
Complete news archive for Spherotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spherotec
Spherotec was founded in 2006 and raised its 1st funding round 11 years after it was founded.
Spherotec is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.
Barbara Mayer is the current CEO of Spherotec. They have also founded this company.
As of Dec 31, 2017, the latest employee count at Spherotec is 3.
Spherote, a spin-off of the Ludwig-Maximillians-Universität München. aiming to optimize oncological therapies through the use of the proprietary Späroid microtumor technology. Spherotec has developed an in vitro analysis method using multicellular spheroid technology. In contrast to conventional cell culture methods and mouse models, spheroid microtumor technology allows realistic functional testing of drugs. The multicellular, three-dimensionally growing spheroid systems have similar biological properties as the microtumors in the clinical situation. The following are the claimed advantages of using the spheroid system - differentiated tumor architecture; small multiplication rate of the cells; tumor heterogeneity; interaction of tumor cells with connective tissue and immune cell; high resistance to therapy. The manufacture of the spheroid systems is quality assured. It is standardized and reproducible according to ISO 9001: 2008 and GLP.
Spherotec's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Spherotec offers Magnetic Beads, Rainbow Calibration, Sphero Beads, and Glutamine Assay Kit.
Spherotec has 2 investors. Key investors include European Union, and EIC Fund.